Search
for
Sort by
Research 121–150 of 248
- Tacrolimus monitoring in hair samples of kidney transplant recipients
- Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions
- Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1
- The JAK/STAT signaling pathway: from bench to clinic
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Baricitinib for the Treatment of Alopecia Areata
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Pharmaceutical care in transplantation: current challenges and future opportunities
- Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride
- ENZYMES
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Design of Nanocrystalline Suspension of Dutasteride for Intramuscular Prolonged Delivery
- Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san
- Pharmacogenetics of the Androgen Metabolic Pathway
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Vitamin D: More Than a “Bone-a-Fide” Hormone
- Meta-Analysis on the Efficacy and Safety of Traditional Chinese Medicine as Adjuvant Therapy for Refractory Androgenetic Alopecia
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Simvastatin-induced myoglobinuric acute kidney injury following ciclosporin treatment for alopecia universalis
- Response Surface Methodology (RSM) approach to formulate and optimize the bilayer combination tablet of Tamsulosin and Finasteride
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy
- Systemic Antifungals
- The Rotterdam Study: objectives and design update
- Stem Cells Applications in Regenerative Medicine and Disease Therapeutics
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects